Patents by Inventor Andrew J. Staab

Andrew J. Staab has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND PROCESSES FOR PREPARING SUBSTITUTED AMINOMETHYL-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e]INDOL-8-ONES
    Publication number: 20100217012
    Abstract: Processes and intermediates are provided for the preparation of substituted aminomethyl 2,3,8,9-tetrahydiO-7H-1,4-dioxino[2.3-e]indo]-8-ones of the Formula (A) wherein the variables n, R and R3 are as described herein. Such compounds are useful, for example, as dopamine receptor agonists.
    Type: Application
    Filed: March 26, 2008
    Publication date: August 26, 2010
    Applicant: NEUROGEN CORPORATION
    Inventors: Zhe-qing Wang, Andrew J. Staab, Christopher K. Seekamp, George P. Luke
  • PROCESS FOR THE PREPARATION OF SUBSTITUTED HETEROCYCLES
    Publication number: 20070161670
    Abstract: The present disclosure generally relates to a process for the preparation of hydroxy-substituted heterocycles such as isoquinolines, naphthyridines, pyridopyridazines, and pyridopyrimidines.
    Type: Application
    Filed: January 4, 2007
    Publication date: July 12, 2007
    Inventors: Andrew J. Staab, Ny Sin
  • 6-thio-substituted paclitaxels
    Patent number: 5977386
    Abstract: The present invention concerns novel paclitaxel derivatives, their use as antitumor agents, and pharmaceutical formulations.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: November 2, 1999
    Assignee: Bristol-Myers Squibb Company
    Inventors: Andrew J. Staab, John F. Kadow, Dolatrai M. Vyas, Mark D. Wittman, Harold A. Mastalerz